Finance

Lists
Why is ATHE down 2.56%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
$2.10
-2.56%
(-0.055) 1D
Oct 23, 11:37:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
$2.12
High
$2.33
Low
$2.07
Mkt. cap
41.58M
Avg. vol.
25.78K
Volume
11.81K
52-wk high
$5.89
52-wk low
$2.07
EPS
-$0.94
Beta
0.29
Shares outstanding
19.10M
No. of employees
11
Open
$2.12
High
$2.33
Low
$2.07
Mkt. cap
41.58M
Avg. vol.
25.78K
Volume
11.81K
52-wk high
$5.89
52-wk low
$2.07
EPS
-$0.94
Beta
0.29
Shares outstanding
19.10M
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitealteritytherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current $2.10
$16.00 (+663.72%)
Average
$13.67 (+552.51%)
Lowest
$10.00 (+377.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
$10.00
+377.3%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
$15.00
+616%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$16.00
+663.7%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+377.3%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+377.3%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$12.00
+472.8%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.40M
1.40M
403.29K
403.29K
Cost of goods sold
49.43K
49.43K
81.96K
81.96K
Cost of revenue
49.43K
49.43K
81.96K
81.96K
Research and development expenses
3.92M
3.92M
4.89M
4.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.56M
2.56M
2.71M
2.71M
Operating expense
6.57M
6.57M
7.65M
7.65M
Total operating expenses
6.62M
6.62M
7.73M
7.73M
Operating income
-5.22M
-5.22M
-7.32M
-7.32M
Other non operating income
-
-
-
-
EBT including unusual items
-4.78M
-4.78M
-6.87M
-6.87M
EBT excluding unusual items
-4.78M
-4.78M
-6.87M
-6.87M
Income tax expense
30.78K
30.78K
25.97K
25.97K
Effective tax rate
-0.64%
-0.64%
-0.38%
-0.38%
Other operating expenses
95.67K
95.67K
46.26K
46.26K
Net income
-4.81M
-4.81M
-6.89M
-6.89M
Net profit margin
-343.00%
-343.00%
-1,709.06%
-1,709.06%
Earnings per share
-
-
-
-
Interest and investment income
454.88K
454.88K
403.45K
403.45K
Interest expense
-
-
-
-
Net interest expenses
454.88K
454.88K
403.45K
403.45K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.22M
-5.22M
-7.32M
-7.32M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps